Get Real Time Here
| Open3.900 | Close3.805 |
| Vol / Avg.278.900K / 500.584K | Mkt Cap235.000M |
| Day Range3.800 - 3.990 | 52 Wk Range0.991 - 7.330 |
Inozyme Pharma Stock (NASDAQ:INZY), Quotes and News Summary
Inozyme Pharma Stock (NASDAQ: INZY) stock price, news, charts, stock research, profile.
| Open3.900 | Close3.805 |
| Vol / Avg.278.900K / 500.584K | Mkt Cap235.000M |
| Day Range3.800 - 3.990 | 52 Wk Range0.991 - 7.330 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.320 | -0.290 | 0.0300 | ||||
| REV | 0 |
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.430 | -0.350 | 0.0800 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-11-08 | Needham | Joseph Stringer | Reiterates | BuyBuy | Maintains | - | 23.00 |
| 2023-09-27 | Needham | Joseph Stringer | Reiterates | BuyBuy | Maintains | - | 23.00 |
| 2023-09-08 | Wedbush | David Nierengarten | Maintains | OutperformOutperform | Announces | - | 15.00 |
| 2023-08-09 | Needham | Joseph Stringer | Reiterates | BuyBuy | Maintains | - | 23.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| INZY | Inozyme Pharma | -3.18% | 235M |
| RENB | Renovaro Biosciences | -1.79% | 220.1M |
| PGEN | Precigen | 0.85% | 293.7M |
| IMRX | Immuneering | 0.98% | 241.5M |
| FATE | Fate Therapeutics | -4.68% | 220.9M |
How do I buy Inozyme Pharma (INZY) stock?
You can purchase shares of Inozyme Pharma (NASDAQ: INZY) through any online brokerage.
Who are Inozyme Pharma's (INZY) competitors?
Other companies in Inozyme Pharma’s space includes: Renovaro Biosciences (NASDAQ:RENB), Precigen (NASDAQ:PGEN), Immuneering (NASDAQ:IMRX), Fate Therapeutics (NASDAQ:FATE) and Opthea (NASDAQ:OPT).
What is the target price for Inozyme Pharma (INZY) stock?
The latest price target for Inozyme Pharma (NASDAQ: INZY) was reported by Needham on Wednesday, November 8, 2023. The analyst firm set a price target for 23.00 expecting INZY to rise to within 12 months (a possible 504.47% upside). 13 analyst firms have reported ratings in the last year.
Current Stock Price for Inozyme Pharma (INZY)?
The stock price for Inozyme Pharma (NASDAQ: INZY) is $3.805 last updated December 8, 2023 at 9:00 PM UTC.
Does Inozyme Pharma (INZY) pay a dividend?
There is no dividend information for Inozyme Pharma.
When is Inozyme Pharma (NASDAQ:INZY) reporting earnings?
Inozyme Pharma’s Q3 earnings are confirmed for Tuesday, November 7, 2023.
Is Inozyme Pharma (INZY) going to split?
There is no upcoming split for Inozyme Pharma.
What sector and industry does Inozyme Pharma (INZY) operate in?
Inozyme Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.